Has Nissim Khabie, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,531 in general payments to Nissim Khabie, MD across 49 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nissim Khabie, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nissim Khabie, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nissim Khabie, MD

Otolaryngology · Minneapolis, MNNPI 1851393839

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Biohaven Pharmaceuticals, Inc. at 36.6% of the total. Reporting peaked in 2021 at $2,073 and has fallen 92.0% since, to $166 in 2025. Among otolaryngology clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,531in general payments, 2019–2025

Across 49 payments — averaging $112.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biohaven Pharmaceuticals, Inc.$2K
Biohaven Pharmaceutical Holding Company Ltd.$1K
Intersect ENT, Inc.$788
Medical Device Business Services, Inc.$557
Stryker$398
Aerin Medical Inc.$266
plus $485 from 7 others

What the payments were for

Consulting fees$3,03855%
Travel & lodging$86216%
Food & beverage$1,63230%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biohaven Pharmaceuticals, Inc.	4	$2,025
Biohaven Pharmaceutical Holding Company Ltd.	1	$1,013
Intersect ENT, Inc.	7	$788
Medical Device Business Services, Inc.	1	$557
Stryker	12	$398
Aerin Medical Inc.	6	$266
Acclarent, Inc	6	$196
Inspire Medical Systems, Inc.	3	$124
GSK	4	$71
Hologic Sales And Service, LLC	1	$29
Optinose US, Inc.	2	$29
Regeneron Healthcare Solutions, Inc.	1	$19
KARL Storz Endoscopy-america	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

PROPEL$647
SINUVA$647
TruDi Navigation System$557
TruDi Nav Suction$557
TruDi Nav Cable$557
ACCLARENT NAVWIRE Sinus Navigation Guidewire$557
ENTELLUS - OFFICE SINUS PROCEDURE PACK$107

How this compares

$5,531 in reported general payments places this provider in the 90th percentile of 181 otolaryngology providers in Minnesota.

See all otolaryngology providers in Minnesota →

Medicare billing

Part B allowed, 2024

$104,839

Medicare patients

234

Services billed

847

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Mometasone Furoate	78	$4,547
Azelastine Hcl	143	$3,453
Ipratropium Bromide	83	$3,281
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	18	$2,162
Fluticasone Propionate	85	$1,474
Oxycodone Hcl	36	$517
Ofloxacin	17	$480
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	30	$436
Omeprazole	22	$222
Cephalexin	20	$197
Doxycycline Monohydrate	11	$169
Fluconazole	13	$165
Amoxicillin	15	$116
Mupirocin	16	$108
Prednisone	52	$98

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Minneapolis

Samuel LevineMinneapolis$151K
George GodingMinneapolis$143K
Michael PaparellaMinneapolis$22K
Oleg FroymovichMinneapolis$20K
Robert TibesarMinneapolis$6K
Benjamin OstranderMinneapolis$4K
Neal GodseMinneapolis$2K
Karin EvanMinneapolis$2K
Darren McDonaldMinneapolis$2K
Kolin RubelMinneapolis$1K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →